Key result
Acute myeloid leukemia is linked to impaired platelet aggregation, release reactions, and reduced thromboxane B2.
Observational (n=13)
Answers are grounded in this paper and cite their sources.
Demonstrates impaired aggregation and deficient thromboxane B2 production in acute myeloid leukaemia platelets, suggesting a biochemical mechanism for bleeding complications.
In a study of platelets from 13 patients with acute myeloid leukaemia abnormal aggregation and release reactions were found. A previously unrecognised quantitative defect of thromboxane B2 production may, at least in part, explain these findings. In contrast to a previous report, we were unable to show a convincing storage pool defect in these platelets. The platelet membrane glycoproteins were largely normal.
No takes yet. Share an insight, caveat, or question.
Woodcock et al. (1984) conducted an observational in Acute myeloid leukaemia (n=13). Acute myeloid leukaemia was evaluated on Platelet aggregation, release reactions, and thromboxane B2 production. Platelets from 13 patients with acute myeloid leukaemia exhibited abnormal aggregation and release reactions alongside a quantitative defect in thromboxane B2 production.
Synapse has enriched 10 related papers. Consider them for comparative context: